Integra LifeSciences Holdings Corp (IART)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Integra LifeSciences Holdings Corp (IART) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014359
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Integra LifeSciences Holdings Corp (Integra) is a medical technology company. Integra’s orthopedics products comprise specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. The company’s neurosurgery products consist of ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra solutions find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp (IART) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Integra LifeSciences Holdings Corp, Medical Devices Deals, 2011 to YTD 2017 9
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Medistim Enters Into Distribution Agreement With Integra LifeSciences 11
Acquisition 12
Integra LifeSciences to Acquire Derma Sciences in Tender Offer 12
Integra LifeSciences Acquires TEI Medical and TEI Biosciences for USD312 Million 14
Integra LifeSciences Holdings Corp – Key Competitors 15
Integra LifeSciences Holdings Corp – Key Employees 16
Integra LifeSciences Holdings Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 21
Financial Announcements 21
Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results 21
Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 23
Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 25
Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 27
Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 29
Jul 28, 2016: Integra LifeSciences Reports Second Quarter 2016 Financial Results 30
Apr 27, 2016: Integra LifeSciences Reports First Quarter 2016 Financial Results 32
Feb 25, 2016: Integra LifeSciences Reports Fourth Quarter and Full Year 2015 Financial Results and Issues 2016 Full Year Guidance 33
Corporate Communications 35
Dec 05, 2016: Integra LifeSciences announces management changes 35
Other Significant Developments 36
Sep 26, 2017: Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Anasco, Puerto Rico 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Integra LifeSciences Holdings Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Integra LifeSciences Holdings Corp, Medical Devices Deals, 2011 to YTD 2017 9
Integra LifeSciences Holdings Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Medistim Enters Into Distribution Agreement With Integra LifeSciences 11
Integra LifeSciences to Acquire Derma Sciences in Tender Offer 12
Integra LifeSciences Acquires TEI Medical and TEI Biosciences for USD312 Million 14
Integra LifeSciences Holdings Corp, Key Competitors 15
Integra LifeSciences Holdings Corp, Key Employees 16
Integra LifeSciences Holdings Corp, Other Locations 17
Integra LifeSciences Holdings Corp, Subsidiaries 17

★海外企業調査レポート[Integra LifeSciences Holdings Corp (IART)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Twist Bioscience Corp (TWST):医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a provider of synthetic DNA Tools. Its silicon-based DNA synthesis platform enables precise synthesis and sequencing process and production of synthetic DNA tools. The company offers its products which include DNA tools for gRNA cloning such as una …
  • Hobby Lobby Stores Inc:企業の戦略・SWOT・財務情報
    Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Hobby Lobby Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • CooperVision Inc:医療機器:M&Aディール及び事業提携情報
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Saneca Pharmaceuticals as:製薬・医療:M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Silgan Holdings Inc. (SLGN):企業の財務・戦略的SWOT分析
    Silgan Holdings Inc. (SLGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Acceleron Pharma Inc (XLRN)-製薬・医療分野:企業M&A・提携分析
    Summary Acceleron Pharma Inc (AcceleronPharma) is a clinical stage biopharmaceutical company that discovers, developsand commercializes therapeuticsto treat serious and rare diseases. The company’s lead therapeutic candidate, luspatercept, is in phase 3 studyused for the treatment of the myelodyspla …
  • Aeglea BioTherapeutics Inc (AGLE):企業の財務・戦略的SWOT分析
    Summary Aeglea BioTherapeutics Inc (Aeglea BioTherapeutics), formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company’s product pipeline comprises AEB1102, AEB …
  • Neurimmune Holding AG-製薬・医療分野:企業M&A・提携分析
    Summary Neurimmune Holding AG (Neurimmune), formerly known as Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human disorders with a f …
  • ARCA biopharma Inc (ABIO):製薬・医療:M&Aディール及び事業提携情報
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • A.P. Eagers Limited:企業の戦略・SWOT・財務情報
    A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • RPC Group PLC:企業の戦略・SWOT・財務情報
    RPC Group PLC - Strategy, SWOT and Corporate Finance Report Summary RPC Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Valvoline Inc (VVV):企業の財務・戦略的SWOT分析
    Valvoline Inc (VVV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Can-Fite BioPharma Ltd (CANF):企業の財務・戦略的SWOT分析
    Summary Can-Fite BioPharma Ltd (Can-Fite) is a clinical stage drug development Company that strives to develop small molecule drugs for the treatment of cancer and inflammatory diseases. The company’s pipeline products which are in phase II and III clinical development stage includes CF101, for rheu …
  • Shanghai Kehua Bio-engineering Co Ltd (002022)-医療機器分野:企業M&A・提携分析
    Summary Shanghai Kehua Bio-engineering Co Ltd (KHB) is a medical device company that develops, manufactures and markets in vitro diagnostic devices and related products. The company’s product portfolio includes enzyme immunoassay kits, clinical chemistry reagents, PCR kits, rapid test kits and labor …
  • BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary BowLeven plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operation …
  • Global Payments Inc. (GPN):企業の財務・戦略的SWOT分析
    Global Payments Inc. (GPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SomaLogic Inc:企業の製品パイプライン分析
    Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products. The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the pr …
  • Bioprognos SL:企業の製品パイプライン分析2018
    Summary Bioprognos SL (Bioprognos) is a cancer diagnostics company that develops non-invasive and accurate diagnostics solutions. The company’s pipeline products include OncoBREAST Dx, OncoLUNG Dx, OncoOVARIAN Dx, OncoPROSTATE Dx, OncoCUP Dx, OncoLIVER Dx, OncoNECK Dx, OncoBLADDER Dx, and OncoCOLON …
  • BP Plc (BP.)-エネルギー分野:企業M&A・提携分析
    Summary BP p.l.c. (BP) is an integrated oil and gas company. It provides fuel, energy, lubricants and petrochemicals to its customers. Its upstream activities include oil and natural gas exploration, field development and production; and midstream operations include transportation, and marketing and …
  • Avisa Pharma Inc-医療機器分野:企業M&A・提携分析
    Summary Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company’s product include avisa breath test kit, which is designed to detect respiratory bacterial infections in the lung and other metabolic diseases; …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆